Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
64.23
+3.05 (4.99%)
At close: Mar 9, 2026, 4:00 PM EDT
64.23
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:41 PM EDT
Disc Medicine Employees
Disc Medicine had 155 employees as of December 31, 2025. The number of employees increased by 71 or 84.52% compared to the previous year.
Employees
155
Change (1Y)
71
Growth (1Y)
84.52%
Revenue / Employee
n/a
Profits / Employee
-$1,368,929
Market Cap
2.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 155 | 71 | 84.52% |
| Dec 31, 2024 | 84 | 10 | 13.51% |
| Dec 31, 2023 | 74 | 28 | 60.87% |
| Dec 31, 2022 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Adaptive Biotechnologies | 624 |
| Galapagos NV | 558 |
| Travere Therapeutics | 497 |
| Ocular Therapeutix | 325 |
| Wave Life Sciences | 317 |
| Dyne Therapeutics | 258 |
| Day One Biopharmaceuticals | 178 |
IRON News
- 11 days ago - Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 20 days ago - Disc Medicine, Inc. (IRON) Discusses FDA Complete Response Letter and Path Forward for Bitopertin Regulatory Approval Transcript - Seeking Alpha
- 20 days ago - Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route - Reuters
- 24 days ago - US FDA declines to approve Disc Medicine's rare disease drug - Reuters
- 24 days ago - Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP - GlobeNewsWire
- 7 weeks ago - Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action - Benzinga
- 7 weeks ago - Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer - GlobeNewsWire